Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis

BACKGROUND: Dual antiplatelet therapy is usually superior to mono therapy in preventing recurrent vascular events (VEs). This systematic review assesses the safety and efficacy of triple antiplatelet therapy in comparison with dual therapy in reducing recurrent vascular events. METHODS: Completed ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Geeganage, Chamila, Wilcox, Robert, Bath, Philip MW
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893089/
https://www.ncbi.nlm.nih.gov/pubmed/20553581
http://dx.doi.org/10.1186/1741-7015-8-36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893089/
https://www.ncbi.nlm.nih.gov/pubmed/20553581
http://dx.doi.org/10.1186/1741-7015-8-36

Ejemplares similares